CN Patent

CN1222082A — 含有抗真菌剂和乙酸盐缓冲液的组合物

Assigned to Merck Sharp and Dohme LLC · Expires 1999-07-07 · 27y expired

What this patent protects

本发明为用于静脉给予病人的药用组合物,包括a)药用有效量的式(Ⅰ)的化合物和其药学上可接受的盐;b)药学上可接受量的赋形剂例如有效的填充剂以形成冻干饼状物;和c)药学上可接受量的有效的乙酸盐缓冲液以得到pH在约4和7之间。

USPTO Abstract

本发明为用于静脉给予病人的药用组合物,包括a)药用有效量的式(Ⅰ)的化合物和其药学上可接受的盐;b)药学上可接受量的赋形剂例如有效的填充剂以形成冻干饼状物;和c)药学上可接受量的有效的乙酸盐缓冲液以得到pH在约4和7之间。

Drugs covered by this patent

rezafungin-acetate (REZAFUNGIN ACETATE)

Patent Metadata

Patent number: CN1222082A
Jurisdiction: CN
Classification: —
Expires: 1999-07-07
Drug substance claim: No
Drug product claim: No
Assignee: Merck Sharp and Dohme LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.